BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9234683)

  • 1. tau4/tau c/AF-2 of the thyroid hormone receptor relieves silencing of the retinoic acid receptor silencer core independent of both tau4 activation function and full dissociation of corepressors.
    Baniahmad A; Thormeyer D; Renkawitz R
    Mol Cell Biol; 1997 Aug; 17(8):4259-71. PubMed ID: 9234683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-specific inhibition of retinoic acid receptor-alpha silencing by the AF2/tau c activation domain can be overcome by the corepressor SMRT, but not by N-CoR.
    Baniahmad A; Dressel U; Renkawitz R
    Mol Endocrinol; 1998 Apr; 12(4):504-12. PubMed ID: 9544986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor.
    Tong GX; Jeyakumar M; Tanen MR; Bagchi MK
    Mol Cell Biol; 1996 May; 16(5):1909-20. PubMed ID: 8628257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
    Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators.
    Tagami T; Lutz WH; Kumar R; Jameson JL
    Biochem Biophys Res Commun; 1998 Dec; 253(2):358-63. PubMed ID: 9878542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT.
    Li H; Leo C; Schroen DJ; Chen JD
    Mol Endocrinol; 1997 Dec; 11(13):2025-37. PubMed ID: 9415406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation.
    Qi JS; Desai-Yajnik V; Greene ME; Raaka BM; Samuels HH
    Mol Cell Biol; 1995 Mar; 15(3):1817-25. PubMed ID: 7862171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT).
    Shibata H; Nawaz Z; Tsai SY; O'Malley BW; Tsai MJ
    Mol Endocrinol; 1997 Jun; 11(6):714-24. PubMed ID: 9171235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A regulatory role for RIP140 in nuclear receptor activation.
    Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
    Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corepressor SMRT functions as a coactivator for thyroid hormone receptor T3Ralpha from a negative hormone response element.
    Berghagen H; Ragnhildstveit E; Krogsrud K; Thuestad G; Apriletti J; Saatcioglu F
    J Biol Chem; 2002 Dec; 277(51):49517-22. PubMed ID: 12388540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nuclear corepressors recognize distinct nuclear receptor complexes.
    Cohen RN; Putney A; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2000 Jun; 14(6):900-14. PubMed ID: 10847591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor.
    Hörlein AJ; Näär AM; Heinzel T; Torchia J; Gloss B; Kurokawa R; Ryan A; Kamei Y; Söderström M; Glass CK
    Nature; 1995 Oct; 377(6548):397-404. PubMed ID: 7566114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid receptors beta and gamma do not repress, but instead activate target gene transcription in both the absence and presence of hormone ligand.
    Hauksdottir H; Farboud B; Privalsky ML
    Mol Endocrinol; 2003 Mar; 17(3):373-85. PubMed ID: 12554770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR.
    Seol W; Mahon MJ; Lee YK; Moore DD
    Mol Endocrinol; 1996 Dec; 10(12):1646-55. PubMed ID: 8961273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterodimeric interaction of the retinoic acid and thyroid hormone receptors in transcriptional regulation on the gamma F-crystallin everted retinoic acid response element.
    Tini M; Tsui LC; Giguère V
    Mol Endocrinol; 1994 Nov; 8(11):1494-506. PubMed ID: 7877618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in dominant negative activities between mutant thyroid hormone receptors alpha1 and beta1 with an identical truncation in the extreme carboxyl-terminal tau4 domain.
    Nishiyama K; Andoh S; Kitahara A; Natsume H; Mikami T; Genma R; Nakamura H
    Mol Cell Endocrinol; 1998 Mar; 138(1-2):95-104. PubMed ID: 9685218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
    Jeyakumar M; Tanen MR; Bagchi MK
    Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators.
    Huang N; vom Baur E; Garnier JM; Lerouge T; Vonesch JL; Lutz Y; Chambon P; Losson R
    EMBO J; 1998 Jun; 17(12):3398-412. PubMed ID: 9628876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation.
    Au-Fliegner M; Helmer E; Casanova J; Raaka BM; Samuels HH
    Mol Cell Biol; 1993 Sep; 13(9):5725-37. PubMed ID: 8395010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic inhibition of nuclear receptor activation by corepressor binding.
    Sohn YC; Kim SW; Lee S; Kong YY; Na DS; Lee SK; Lee JW
    Mol Endocrinol; 2003 Mar; 17(3):366-72. PubMed ID: 12554786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.